These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 28900509)

  • 1. Biodegradable Hollow Mesoporous Silica Nanoparticles for Regulating Tumor Microenvironment and Enhancing Antitumor Efficiency.
    Kong M; Tang J; Qiao Q; Wu T; Qi Y; Tan S; Gao X; Zhang Z
    Theranostics; 2017; 7(13):3276-3292. PubMed ID: 28900509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Cell Membrane Camouflaged Mesoporous Silica Nanoparticles Combined with Immune Checkpoint Blockade for Regulating Tumor Microenvironment and Enhancing Antitumor Therapy.
    Zhao P; Qiu L; Zhou S; Li L; Qian Z; Zhang H
    Int J Nanomedicine; 2021; 16():2107-2121. PubMed ID: 33737808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy.
    Liu Y; Qiao L; Zhang S; Wan G; Chen B; Zhou P; Zhang N; Wang Y
    Acta Biomater; 2018 Jan; 66():310-324. PubMed ID: 29129789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hollow mesoporous silica nanoparticles facilitated drug delivery via cascade pH stimuli in tumor microenvironment for tumor therapy.
    Liu J; Luo Z; Zhang J; Luo T; Zhou J; Zhao X; Cai K
    Biomaterials; 2016 Mar; 83():51-65. PubMed ID: 26773665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-Therapeutics-Loaded Mesoporous Silica Nanoparticles Applied for Breast Tumor Therapy.
    Li X; He G; Jin H; Tao J; Li X; Zhai C; Luo Y; Liu X
    ACS Appl Mater Interfaces; 2019 Dec; 11(50):46497-46503. PubMed ID: 31738505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
    Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Encapsulation of Hydrophilic and Hydrophobic Peptides into Hollow Mesoporous Silica Nanoparticles for Enhancement of Antitumor Immune Response.
    Xie J; Yang C; Liu Q; Li J; Liang R; Shen C; Zhang Y; Wang K; Liu L; Shezad K; Sullivan M; Xu Y; Shen G; Tao J; Zhu J; Zhang Z
    Small; 2017 Oct; 13(40):. PubMed ID: 28861951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-delivery of Doxorubicin and Interferon-γ by Thermosensitive Nanoparticles for Cancer Immunochemotherapy.
    Yin Y; Hu Q; Xu C; Qiao Q; Qin X; Song Q; Peng Y; Zhao Y; Zhang Z
    Mol Pharm; 2018 Sep; 15(9):4161-4172. PubMed ID: 30011369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-delivery of doxorubicin and interleukin-2 via chitosan based nanoparticles for enhanced antitumor efficacy.
    Wu J; Tang C; Yin C
    Acta Biomater; 2017 Jan; 47():81-90. PubMed ID: 27729232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coordination-Accelerated "Iron Extraction" Enables Fast Biodegradation of Mesoporous Silica-Based Hollow Nanoparticles.
    Wang L; Huo M; Chen Y; Shi J
    Adv Healthc Mater; 2017 Nov; 6(22):. PubMed ID: 28941142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Effect of Doxorubicin-Chlorin E6-Loaded Mesoporous Silica Nanoparticles Combined with Ultrasound on Triple-Negative Breast Cancer.
    Xu P; Yao J; Li Z; Wang M; Zhou L; Zhong G; Zheng Y; Li N; Zhai Z; Yang S; Wu Y; Zhang D; Dai Z
    Int J Nanomedicine; 2020; 15():2659-2668. PubMed ID: 32368047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quercetin and doxorubicin co-delivery using mesoporous silica nanoparticles enhance the efficacy of gastric carcinoma chemotherapy.
    Fang J; Zhang S; Xue X; Zhu X; Song S; Wang B; Jiang L; Qin M; Liang H; Gao L
    Int J Nanomedicine; 2018; 13():5113-5126. PubMed ID: 30233175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-Loaded Mesoporous Silica Nanoparticles Enhance Antitumor Immunotherapy by Regulating MDSCs.
    Xu C; Amna N; Shi Y; Sun R; Weng C; Chen J; Dai H; Wang C
    Molecules; 2024 May; 29(11):. PubMed ID: 38893313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
    Ma X; Zhao Y; Ng KW; Zhao Y
    Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface-Layer Protein-Enhanced Immunotherapy Based on Cell Membrane-Coated Nanoparticles for the Effective Inhibition of Tumor Growth and Metastasis.
    Wu M; Liu X; Bai H; Lai L; Chen Q; Huang G; Liu B; Tang G
    ACS Appl Mater Interfaces; 2019 Mar; 11(10):9850-9859. PubMed ID: 30788951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular redox-activated anticancer drug delivery by functionalized hollow mesoporous silica nanoreservoirs with tumor specificity.
    Luo Z; Hu Y; Cai K; Ding X; Zhang Q; Li M; Ma X; Zhang B; Zeng Y; Li P; Li J; Liu J; Zhao Y
    Biomaterials; 2014 Sep; 35(27):7951-62. PubMed ID: 24930850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
    Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW
    Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zwitterionic mesoporous nanoparticles with a bioresponsive gatekeeper for cancer therapy.
    Khatoon S; Han HS; Lee M; Lee H; Jung DW; Thambi T; Ikram M; Kang YM; Yi GR; Park JH
    Acta Biomater; 2016 Aug; 40():282-292. PubMed ID: 27063494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ biodegradable crosslinking of cationic oligomer coating on mesoporous silica nanoparticles for drug delivery.
    Wang Y; Wang J; Yang Y; Sun Y; Yuan Y; Li Y; Liu C
    Colloids Surf B Biointerfaces; 2017 May; 153():272-279. PubMed ID: 28279933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodegradable hybrid mesoporous silica nanoparticles for gene/chemo-synergetic therapy of breast cancer.
    Zhang B; Liu Q; Liu M; Shi P; Zhu L; Zhang L; Li R
    J Biomater Appl; 2019 May; 33(10):1382-1393. PubMed ID: 30880565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.